[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2613 followers
Created: 2023-08-22 20:20:43 UTC

Pharma/Biotech Highlights:

$RVVTF: Revive develops new formulation for bucillamine.
$GERN: Geron schedules Imetelstat NDA's PDUFA.
$SLS: Data monitoring committee recommends continuing Galinpepimut-S trial.
$LLY: Lilly's Retevmo triumphs, treating thyroid cancer.

![](https://pbs.twimg.com/media/F4KWxctWQAAdXeY.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1694082191351762945/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[$sls](/topic/$sls)
[$rvvtf](/topic/$rvvtf)
[$gern](/topic/$gern)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/OzmosiHealth/status/1694082191351762945)